Vascular Grafts (Cardiovascular Devices) - Global Market Analysis and Forecast Model

Researchmoz added latest report "Vascular Grafts (Cardiovascular Devices) - Global Market Analysis and Forecast Model". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
Vascular Grafts (Cardiovascular Devices) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

Vascular Grafts are used to treat conditions which require aortic repair or peripheral vessel bypass. These conditions include aortic aneurysms that occur in both the thoracic aorta (Thoracic Aortic Aneurysms - TAA) and abdominal aorta (Abdominal Aortic Aneurysms - AAA), aortic dissections, peripheral artery disease (PAD) and end-stage renal disease cases that have insufficient vasculature to support hemodialysis. Vascular Grafts are tubes made up of synthetic materials surgically implanted in the veins and arteries. These are the implants used to repair, bypass or replace sections of blood vessels during surgical procedures. They are also used to patch injured or diseased areas in the arteries and for the replacement of whole segments of larger arteries such as the aorta.

Get a Sample PDF at: https://www.researchmoz.us/enquiry.php?type=S&repid=1978285

Each of the covered 39 countrys color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model

Currently marketed vascular grafts and evolving competitive landscape -
- Insightful review of the key industry trends.
- Annualized total vascular grafts market revenue by segment and market outlooks from 2015-2028.
- Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
- SWOT analysis for Vascular Grafts market.
- Competitive dynamics insights and trends provided for Vascular Grafts market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: B. Braun Melsungen AG, Becton Dickinson GmbH, Getinge AB, Japan Lifeline Co Ltd, LeMaitre Vascular Inc, Terumo Aortic, W. L. Gore & Associates Inc, CryoLife Inc., Nicast Ltd., Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you wont find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
- CMO executives who must have deep understanding of the vascular grafts marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/vascular-grafts-cardiovascular-devices-global-market-analysis-and-forecast-model-report.html/toc

Reasons to buy

The model will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving vascular grafts market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the vascular grafts market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Track device sales in the global and country-specific vascular grafts market from 2015-2028.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

About ResearchMoz

ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfil all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organisations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

For More Information Kindly Contact:

ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us

For More Reports Visit @ http://marketresearchlatestreports.blogspot.com/

Global Peripheral Vascular Stents Market To Grow At A CAGR Of 7.96% During The Period 2017-2021 : Boston Scientific, Abbott, Medtronic, Cook, C. R. Bard

Researchmoz added Most up-to-date research on "Global Peripheral Vascular Stents Market 2017-2021" to its huge collection of research reports.

Peripheral vascular stents are most commonly used in treating conditions called as PVDs. It is crampy leg pain that occurs during walking and exercise. It occurs in individuals aged 65 and above and is the result of atherosclerosis (hardening of the arteries), which occurs due to scar tissue and cholesterol build up, forming a substance called plaque inside the arteries.

Technavios analysts forecast the global peripheral vascular stents market to grow at a CAGR of 7.96% during the period 2017-2021.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1320846

Covered in this report
The report covers the present scenario and the growth prospects of the global peripheral vascular stents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Global Peripheral Vascular Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Boston Scientific
Abbott
Medtronic
Cook
C. R. Bard
BIOTRONIK
Cordis (a Cardinal Health company)

Other prominent vendors
480 Biomedical
Alvimedica
B. Braun Melsungen
Balton
Bentley
Biosensors International Group
ENDOCOR
eucatech
InSitu Technologies
InspireMD
iVascular
KYOTO MEDICAL PLANNING
Meril Life Sciences
optimed
PanMed US
RONTIS
Terumo Medical
Veryan Medical
W. L. Gore & Associates

Market driver
Ubiquity of PAD
For a full, detailed list, view our report

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-peripheral-vascular-stents-market-2017-2021-report.html/toc

Market challenge
Risks and complications associated with peripheral vascular stents
For a full, detailed list, view our report

Market trend
Technology caters the pace for advances in stenting
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

Global Coronary Artery Disease Therapeutics Market To Grow At A CAGR Of 5.17% During The Period 2017-2021 : AstraZeneca, Gilead, Novartis, Pfizer

Researchmoz added Most up-to-date research on "Global Coronary Artery Disease Therapeutics Market 2017-2021" to its huge collection of research reports.

Coronary artery disease (CAD) is the most common type of heart disease and is one of the leading causes of death globally. It can lead to complications including myocardial infarction, stable angina, unstable angina, and sudden cardiac death. CAD is the narrowing of the coronary arteries that prevents the supply of an adequate amount of blood supply to the heart. It happens when a coronary artery gets hardened or narrowed due to various reasons such as the build-up of cholesterol or other materials known as plaque on the inner wall of the artery. This build-up is known as atherosclerosis. With passing time, a lesser amount of blood flows through the arteries. As a result heart muscle fails to get the required amount of blood or oxygen.

Technavios analysts forecast the global coronary artery disease therapeutics market to grow at a CAGR of 5.17% during the period 2017-2021.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1378191

Covered in this report
The report covers the present scenario and the growth prospects of the global coronary artery disease therapeutics market for 2017-2021. To calculate the market size, the report considers the sales of branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Global Coronary Artery Disease Therapeutics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AstraZeneca
Gilead
Novartis
Pfizer
Other prominent vendors
Bayer,
Bristol-Myers Squibb,
GlaxoSmithKline,
Merck,
Mylan,
Teva Pharmaceutical Industries

Market driver
Growing geriatric population
For a full, detailed list, view our report

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-coronary-artery-disease-therapeutics-market-2017-2021-report.html/toc

Market challenge
Highly genericized market
For a full, detailed list, view our report

Market trend
Growing strategic alliances
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

Global Vascular Stents Market To Grow At A CAGR Of 7.22% During The Period 2017-2021 : Abbott, Boston Scientific, Cardinal Health, Cook Medical

Researchmoz added Most up-to-date research on "Global Vascular Stents Market 2017-2021" to its huge collection of research reports.

Vascular stents are used to treat diseases such as coronary artery diseases (CADs) peripheral artery diseases (PADs), cardiovascular diseases (CVDs), and stroke. The global vascular stents market is driven by technologically advanced and minimally invasive products. The incidence of diseases associated with vascular stents has been increasing globally, where the blood supply gets obstructed due to the deposition of calcified plaque in coronary arteries that supply blood to the heart muscles or peripheral arteries, which supply blood to the head, arms, stomach, and legs.

Technavios analysts forecast the global vascular stents market to grow at a CAGR of 7.22% during the period 2017-2021.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1320830

Covered in this report
The report covers the present scenario and the growth prospects of the global vascular stents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Global Vascular Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott
Boston Scientific
Cardinal Health
Cook Medical
Medtronic

Other prominent vendors
B. Braun
Biosensors International
BIOTRONIK
Fortimedix Surgical
InspireMD
lepumedical
Meril Life Sciences
MicroPort Scientific
Neovasc
SORIN GROUP
Terumo Medical
W. L. Gore & Associates

Market driver
Increasing burden of vascular diseases
For a full, detailed list, view our report

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-vascular-stents-market-2017-2021-report.html/toc

Market challenge
Stringent regulations for product approval
For a full, detailed list, view our report

Market trend
Technological advances in stents
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

Global Cardiac Rhythm Management (CRM) Devices Market To Grow At A CAGR Of 7.64% During The Period 2017-2021 : Abbott, Boston Scientific, Medtronic

Researchmoz added Most up-to-date research on "Global Cardiac Rhythm Management (CRM) Devices Market 2017-2021" to its huge collection of research reports.

CRM devices are used for treating all the major heart conditions such as coronary artery disease (CAD), stroke, cardiac arrest, and arrhythmia. The global CRM devices market is increasing owing to the rising prevalence of CVDs, increasing uptake of MCT, and growing patient awareness. There are three types of CRM devices available such as defibrillators, pacemakers, and CRT devices. The global pacemakers market will grow at a rapid pace followed by defibrillators and CRT devices. By geography, the Americas, EMEA, and APAC will showcase rapid growth rate during the forecast period. APAC will grow at the fastest pace during the forecast period followed by EMEA and the Americas.

Technavios analysts forecast the global cardiac rhythm management (CRM) devices market to grow at a CAGR of 7.64% during the period 2017-2021.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1377957

Covered in this report
The report covers the present scenario and the growth prospects of the global cardiac rhythm management (CRM) devices market for 2017-2021. To calculate the market size, the report considers the total sales volume and the revenue generated from it.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Global Cardiac Rhythm Management (CRM) Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott
Boston Scientific
Medtronic

Other prominent vendors
BIOTRONIK
Cardiac Science
CCC Medical Devices (acquired by Greatbatch)
Cook Medical
GE Healthcare
Integer
Mortara Instrument (acquired by Hill-Rom Holdings)
Neovasc
Philips Healthcare
Physio-Control (Subsidiary of Stryker)
Rchling Medical
Schiller
LivaNova
ZOLL Medical

Market driver
Rising incidence of CVDs
For a full, detailed list, view our report

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-cardiac-rhythm-management-crm-devices-market-2017-2021-report.html/toc

Market challenge
Dearth of skilled healthcare professionals
For a full, detailed list, view our report

Market trend
Technological advances
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

Global Drug Eluting Balloons Market To Grow At A CAGR Of 27.14% During The Period 2017-2021

Researchmoz added Most up-to-date research on "Global Drug Eluting Balloons (DEBs) Market 2017-2021" to its huge collection of research reports.

A DEB, also known as a drug-coated balloon (DCB), is an advanced technology used in the treatment of coronary and peripheral arterial diseases. These diseases cause narrowing of arteries leading to blockages. A DEB is used along with paclitaxel, an anti-proliferative drug, which helps in removing plaque from the walls of arteries and widening them. DEBs are primarily used in the treatment of two types of diseases: Peripheral arterial diseases (PADs), and Coronary arterial diseases (CADs).

Technavios analysts forecast the global drug eluting balloons market to grow at a CAGR of 27.14% during the period 2017-2021.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1180481

Covered in this report
The report covers the present scenario and the growth prospects of the global drug eluting balloons market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of DEBs.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Global Drug Eluting Balloons Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
B. Braun Melsungen
Cook Medical
C.R. Bard
Eurocor
Medtronic


Other prominent vendors
Aachen Resonance
Acrostak
Cardionovum
Spectranetics

Market driver
Growing demand for cath labs
For a full, detailed list, view our report

Get Complete TOC With Tables and Figures @ https://www.researchmoz.us/global-drug-eluting-balloons-debs-market-2017-2021-report.html/toc

Market challenge
Stringent regulatory process
For a full, detailed list, view our report

Market trend
Favorable reimbursement policies
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Global Next-Generation Biologics Market To Grow At A CAGR Of 14.42% During The Period 2016-2020 Key vendors - F. Hofmann-La Roche, Novo Nordisk, Sanofi, Takeda Pharmaceuticals

Researchmoz added Most up-to-date research on "Global Next-Generation Biologics Market 2016-2020" to its huge collection of research reports.

According to the section 351 of the Public Health Service Act of the US FDA, a biological product is defined as a virus, therapeutic serum, antitoxin, vaccine, toxin, blood, blood component or derivative, analogous product or allergenic product, applicable to the treatment, prevention, or cure of a condition or disease of human beings. Biologic therapeutics include virus, toxins, allergenic products, therapeutic serums, antitoxin, blood components or derivatives, vaccines, blood, proteins (except any chemically synthesized polypeptide), or analogous products, or arsphenamine or derivative of arsphenamine intended for the treatment, prevention, or cure of a disease or condition. The differences between the small molecules and biologics includes the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics usually have a higher molecular weight and a complex molecular structure. They are usually derived from living organisms, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures and light.

Technavios analysts forecast the global next-generation biologics market to grow at a CAGR of 14.42% during the period 2016-2020.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=892950

Covered in this report
The report covers the present scenario and the growth prospects of the global next-generation biologics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of next-generation biologics. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market during the forecast period.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Global Next-generation Biologics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
F. Hofmann-La Roche
Novo Nordisk
Sanofi
Takeda Pharmaceuticals

Browse Detail Report With Full TOC @ https://www.researchmoz.us/global-next-generation-biologics-market-2016-2020-report.html

Other prominent vendors
Aastrom Biosciences
AbbVie
AbGenomics
Acologix
ADC Therapeutics
Adocia
Agensys
AlloCure
AlloSource
ALMAC Group
Alphatec Spine
Ambrx
Amorcyte
Argos Therapeutics
Astellas Pharma
AstraZeneca
Athersys
Avita Medical
Baxter
Bayer HealthCare
Bellicum Pharmaceuticals
BioCardia
Biocon
Biodel
BIOGENOMICS
BioLife Solutions
BioRestorative Therapies
BioTissue Technologies
Bluebird Bio
Boehringer Ingelheim
BrainStorm Cell Therapeutics
Calimmune
Capricor
CARBOGEN AMCIS
Cell Medica
Celldex Therapeutics
Celyad (Cardio3 BioSciences)
Cesca
CryoLife
CSL Behring
Cynata Therapeutics
Daiichi Sankyo
Dance Biopharm
Dendreon
Diasome Pharmaceuticals
DiscGenics
Endo Pharmaceuticals
Esperance Pharmaceuticals
Exsulin
Fate Therapeutics
Fibrocell Science
Formation Biologics
Forticell Bioscience
Fortress Biotech
Gamida Cell
GENEREX
Genmab
Geron
GlaxoSmithKline
Harvard Apparatus Regenerative Technology
Healthpoint
Histogen
Histogenics
Humacyte
Immunocellular Therapeutics
Immunogen
Integra LifeSciences
InVivo Therapeutics
ISTO Technologies
Juno Therapeutics
Juventas Therapeutics
Kairos Therapeutics
Kensey Nash
Kiadis Pharma
Kinetic Concept
Living Cell Technologies
MacroGenics
MannKind
MaxCyte
MedImmune
Medtronic
Mersana Therapeutics
Mesoblast
MiMedx
Nanofiber Solutions
Nanotope
Neuralstem
NewLink Genetics
NGM Biopharmaceuticals
Northwest Biotherapeutics
Novartis
NovaRx
Ocata Therapeutics
Opexa Therapeutics
Oramed Pharmaceuticals
Organovo
Orteq
Orthofix
Osiris Therapeutics
Osteotech
OXFORD BioTherapeutics
Pfizer
PhaseBio Pharmaceuticals
Pluristem Therapeutics
Prima BioMed
Q Therapeutics
ReproCELL
RhinoCyte
RTI Surgical
SanBio
Sangamo
Shire Regenerative Medicine
STEMCELL Technologies
Stemcentrx
Stratatech
Synthon Biopharmaceuticals
TEI Biosciences
Tengion
Thermalin Diabetes
TiGenix
Tissue Genesis
TissueGene
Tolerion
VentriNova
Vericel
VeroScience
ViaCyte
VistaGen Therapeutics
vTv Therapeutics
Wockhardt
XOMA
Zimmer Biomet
Zymeworks

Market driver
Advanced technological innovations
For a full, detailed list, view our report

Market challenge
Complexities in manufacturing of biologics
For a full, detailed list, view our report

Market trend
Development of gene and cell therapy-based products
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=892950

Global Vascular Stents Market To Grow At A CAGR Of 7.22% During The Period 2017-2021 Key Vendors – Abbott, Boston Scientific, Cardinal Health, Cook Medical, Medtronic

Researchmoz added Most up-to-date research on "Global Vascular Stents Market 2017-2021" to its huge collection of research reports.

Vascular stents are used to treat diseases such as coronary artery diseases (CADs) peripheral artery diseases (PADs), cardiovascular diseases (CVDs), and stroke. The global vascular stents market is driven by technologically advanced and minimally invasive products. The incidence of diseases associated with vascular stents has been increasing globally, where the blood supply gets obstructed due to the deposition of calcified plaque in coronary arteries that supply blood to the heart muscles or peripheral arteries, which supply blood to the head, arms, stomach, and legs.

Technavios analysts forecast the global vascular stents market to grow at a CAGR of 7.22% during the period 2017-2021.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1320830

Covered in this report
The report covers the present scenario and the growth prospects of the global vascular stents market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Global Vascular Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott
Boston Scientific
Cardinal Health
Cook Medical
Medtronic

Browse Detail Report With Full TOC @ http://www.researchmoz.us/global-vascular-stents-market-2017-2021-report.html

Other prominent vendors
B. Braun
Biosensors International
BIOTRONIK
Fortimedix Surgical
InspireMD
lepumedical
Meril Life Sciences
MicroPort Scientific
Neovasc
SORIN GROUP
Terumo Medical
W. L. Gore & Associates

Market driver
Increasing burden of vascular diseases
For a full, detailed list, view our report

Market challenge
Stringent regulations for product approval
For a full, detailed list, view our report

Market trend
Technological advances in stents
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1320830

Global Autologous Cell Therapy Market To Grow At A CAGR Of 23.39% During The Period 2017-2021

Researchmoz added Most up-to-date research on "Global Autologous Cell Therapy Market 2017-2021" to its huge collection of research reports.

Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, neurology, and dermatology, to name a few. Autologous cell therapy is one of the fastest growing segments of regenerative medicine and hence, is attracting significant research funds from various quarters.

Technavios analysts forecast the global autologous cell therapy market to grow at a CAGR of 23.39% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global autologous cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of autologous stem cell as well non-stem cell products.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1140762

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Autologous Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Brainstorm Cell Therapeutics
Holostem Advanced Therapies
Osiris Therapeutics
Valeant
Vericel Corporation
Other prominent vendors
AbbVie
American CryoStem
AM-Pharma
Anterogen
apceth Biopharma
Astellas Pharma
Athersys
Baxter International
Beike Biotechnology
BIOTIME
bluebird bio
Bristol-Myers Squibb
Brainxell
Caladrius Biosciences
Cellular Biomedicine Group
Cellular Dynamics International (a subsidiary of Fujifilm)
Cesca Therapeutics
CHA Biotech
Chugai Pharmaceutical
Citospin
Corestem
Cytori Therapeutics
Daiichi Sankyo
Fujifilm
Gamida Cell
Global Stem Cells Group
Grupo Ferrer Internacional
GlaxoSmithKline
Hemostemix
Histocell
International Stem Cell
Ivy Institute of Stem Cells
Japan Regenerative Medicine
Kangstem Biotech
Kiadis Pharma
Laboratorios Salvat
MEDIPOST
Mesoblast
Nuo Therapeutics
Opsis Therapeutics
Pharmicell
Pluristem Therapeutics
Promethera Biosciences
Q Therapeutics
ReNeuron
RHEACELL
Salus Medical Solutions
Sangamo Therapeutics
Shire
Steminent Biotherapeutics
Sumitomo Dainippon Pharma
Taiwan Bio Therapeutics
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Thoratec Corporation
TiGenix
Translational Biosciences
TWO CELLS
U.S. Stem Cell
ViaCyte
VistaGen Therapeutics

Market driver
Increasing demand for effective drugs for cardiac and degenerative disorders
For a full, detailed list, view our report

Market challenge
Critical ethical challenges with respect to stem cell research
For a full, detailed list, view our report

Market trend
Private funding will fuel market growth
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1140762

Global Neurovascular Stents Market To Grow At A CAGR Of 13.02% During The Period 2017-2021

Researchmoz added Most up-to-date research on "Global Neurovascular Stents Market 2017-2021" to its huge collection of research reports.

A neurovascular stent is a small, flexible, tube-like device made of fabric supported by a metal mesh. It is used to treat several conditions in the brain such as stenosis formation in the blood vessels and ischemic stroke, and aneurysm. Neurovascular stents are segmented into two types based on product types such as carotid artery stents and intracranial stents. Carotid artery stents segment contributed for a major share of the market, and intracranial stents segment is expected to grow at a higher rate.

Technavios analysts forecast the global neurovascular stents market to grow at a CAGR of 13.02% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global neurovascular stents market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1059765

Technavio's report, Global Neurovascular Stents Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott Laboratories
Medtronic
Stryker
Terumo Medical

Other prominent vendors
Acandis
Blockade Medical
Codman Neurovascular (Johnson & Johnson)
Cordis
Gore Medical
InspireMD
MicroPort Scientific
STI Laser Industries

Market driver
High incidence rates of cerebral disorders and brain aneurysm.
For a full, detailed list, view our report

Market challenge
Complications associated with neurovascular stent procedures.
For a full, detailed list, view our report

Market trend
Growing research activities coupled with new product launches.
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1059765

Global Angioplasty Balloons Industry Will Grow Steadily At A CAGR Of 3.47% During The Period 2016-2020

Researchmoz added Most up-to-date research on "Global Angioplasty Balloons Market 2016-2020" to its huge collection of research reports.

The global angioplasty balloon market presents significant opportunities for vendors to grow in untapped countries, particularly those in APAC. The market is highly dynamic and characterized by intense competition, with the presence of many global and local players that develop safe, easy-to-use, cost-effective, and widely available products in the market. These companies adopt creative strategies and develop innovative devices to ensure product differentiation. In 2015, Medtronic, Abbott Laboratories, Boston Scientific, and C. R. Bard were the leading vendors in the market.

Technavios analysts forecast the global angioplasty balloons market to grow at a CAGR of 3.47% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global angioplasty balloons market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of the products used during angioplasty and stenting.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=810419

Technavio's report, Global Angioplasty Balloons Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott Laboratories
Boston Scientific
C. R. Bard
Medtronic

Other prominent vendors
Aachen Resonance
Acrostak
Alvimedica Medical devices
AMG International
Angioslide
Arthesys
Asahi Intecc
Atrium Medical
AV Medical
Biotronik
BrosMed
C. R. Bard
Cardionovum
Cook Medical
Gadelius Medical
Kaneka Medix
Lepu Medical
Medinol
Meril Life Sciences
MicroPort Scientific
Natec Medical
QT Vascular
SHOCKWAVE Medical
Smiths Medical
Spectranetics
STENTYS
Svelte medical
Teleflex
Tokai Medical
US Endovascular

Market driver
Incidence of cardiac diseases and adoption of PCI
For a full, detailed list, view our report

Market challenge
High cost of angioplasty balloons and stents
For a full, detailed list, view our report

Market trend
Transforming marketing and sales strategies for angioplasty balloons
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=810419

Global Immunoglobulin Products Market Will Grow Steadily At A CAGR Of 6.84% During The Period 2016-2020 | Researchmoz

Researchmoz added Most up-to-date research on "Global Immunoglobulin Products Market 2016-2020" to its huge collection of research reports.

Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.

Technavios analysts forecast the global immunoglobulin products market to grow at a CAGR of 6.84% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global immunoglobulin products market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunoglobulin products used to treat various autoimmune and immunodeficiency diseases.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=711501

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Immunoglobulin Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Baxalta
Biotest Pharmaceuticals Corp.
CSL Ltd.
Grifols SA
Kedrion SpA
Octapharma

Other prominent vendors
Abeona Therapeutics
Admabiologics
Anthera
Beijing Tiantan Biological Products (China)
Bharat Serums and Vaccines (India)
Bio Products Laboratory
China Biologic Products (China)
Emergent Biosolutions
Gliknik
Greencross
Hansamedical
Hualan Biological Engineering (China)
Immunomedics
Innate Pharma
Integrated Biotherapeutics
Janssen Pharmaceuticals
Kamada
LFB Group (France)
Mitsubishi Tanabe Pharma
Momenta Pharma
Patrys
Shanghai RAAS Blood Products (China)
Sichuan Yuanda Shuyang Pharmaceutical (China)
Sorrento Therapeutics

Market driver
Growing aging population
For a full, detailed list, view our report

Market challenge
High cost of therapy
For a full, detailed list, view our report

Market trend
Patient assistance programs
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=711501

Global Age-Related Macular Degeneration (AMD) Industry Will Grow Steadily At A CAGR Of 7.37% During The Period 2016-2020

Researchmoz added Most up-to-date research on "Global Age-related Macular Degeneration Market 2016-2020" to its huge collection of research reports.

AMD is the degeneration or disintegration of the eye's macula. The macula is a small area of the retina that is responsible for the central vision. AMD can be classified into two types: dry and wet macular degenerations. When the tiny abnormal blood vessels begin growing toward the macula, it develops into wet AMD. Dry AMD occurs when small, yellowish deposits called drusen start accumulating beneath the macula. While some treatments are available for wet AMD; there is no treatment available at the moment for dry AMD.

Technavios analysts forecast the global age-related macular degeneration (AMD) market to grow at a CAGR of 7.37% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global age-related macular degeneration (AMD) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of AMD.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=834747

Technavio's report, Global Age-Related Macular Degeneration (AMD) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals

Other prominent vendors
Alcon
Allergan
Adverum Biotechnologies
Bausch + Lomb
Gilead Sciences
Iconic Therapeutics
Lpath
Neurotech Pharmaceuticals
Ohr Pharmaceutical
Opthea
Ophthotech
PanOptica
Pfizer
Promedior
QLT
Quark
Resolvyx Pharmaceuticals
RXi Pharmaceuticals
Sagent Pharmaceuticals
Santen Pharmaceuticals
Sanwa Kagaku Kenkyusho

Market driver
Increasing reimbursement benefits for AMD drugs
For a full, detailed list, view our report

Market challenge
Availability of alternative therapies
For a full, detailed list, view our report

Market trend
Novel treatment approaches for developing AMD drugs
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=834747